MagVenture announced the U.S. launch of MagVenture Go, a compact and mobile TMS system designed for flexible clinical workflows. Built on the established MagPro R20 platform, the system supports both repetitive TMS (rTMS) and intermittent theta-burst stimulation (iTBS) protocols.
The portable design targets clinics that need to move equipment between rooms or sites, or that want to add TMS capacity without dedicating a fixed treatment suite. By basing the product on the proven MagPro R20 platform, MagVenture aims to give providers a mobile option that retains the protocol flexibility of its larger systems.
The launch came the same month as MagVenture's FDA clearance for accelerated TMS protocols, reinforcing the company's push toward more adaptable treatment delivery.
For smaller and growing practices, a portable system can lower the footprint and cost barriers to offering TMS in the first place.
Source
Reporting based on coverage from MagVenture. This article is editorial summary intended for general information; it is not medical advice.
